EN PT


0195/2025 - Innovation, prioritization and sustainability: current dilemmas for Pharmaceutical Services
Inovação, priorização e sustentabilidade: dilemas contemporâneos da Assistência Farmacêutica

Author:

• Claudia Garcia Serpa Osorio-de-Castro - Osorio-de-Castro, CGS - <claudiaosorio.soc@gmail.com>
ORCID: https://orcid.org/0000-0003-4875-7216

Co-author(s):

• Tatiana de Jesus Nascimento Ferreira - Ferreira, TJN - <tati29ric10@gmail.com>
ORCID: https://orcid.org/0000-0002-9857-9852
• Cláudia Du Bocage Santos-Pinto - Santos-Pinto, CDB - <bocage.santos@ufms.br>
ORCID: https://orcid.org/ 0000-0002-5478-4977
• Elaine Silva Miranda - Miranda, ES - <elainemiranda@id.uff.br>
ORCID: https://orcid.org/0000-0002-6204-5023
• Elisangela Costa Lima - Costa Lima, E - <eclima.ufrj@gmail.com>
ORCID: https://orcid.org/0000-0002-0101-790X
• Mario Jorge Sobreira-da-Silva - Sobreira-da-Silva, MJ - <mjsobreira@yahoo.com.br>
ORCID: https://orcid.org/0000-0002-0477-8595


Abstract:

In the last five years topics related to Pharmaceutical Services have increasingly focused on issues such as technology incorporation, financing, inequalities of access, regulatory challenges, among others. This essay aims to discuss the central role assigned to innovation at the expense of prioritization of essential medicines and its effects on the sustainability of the health system. First-in-class innovations do not always meet health priorities or the established criteria for prioritization. From the health system perspective, innovations that genuinely address an unmet need may be prioritized, provided they are supported by robust evidence. However, it is necessary for the system to have actual structural, financial, technical and human resources conditions –– to adequately implement the technology. The means to overcome the challenges of this misalignment primarily involve improving budget impact analyses and adjusting the regulatory framework for incorporation. The organization, or reorganization, of Pharmaceutical Services depends on timely facing these dilemmas.

Keywords:

Technology and Innovation Policy; Essential Drugs; Technology Assessment; Pharmaceutical Services; Unified Health System

Content:

Access Issue in Scielo

Other languages:







How to

Cite

Osorio-de-Castro, CGS, Ferreira, TJN, Santos-Pinto, CDB, Miranda, ES, Costa Lima, E, Sobreira-da-Silva, MJ. Innovation, prioritization and sustainability: current dilemmas for Pharmaceutical Services. Cien Saude Colet [periódico na internet] (2025/Jun). [Citado em 05/12/2025]. Está disponível em: http://www.cienciaesaudecoletiva.com.br/en/articles/innovation-prioritization-and-sustainability-current-dilemmas-for-pharmaceutical-services/19671



Execution



Sponsors